Seres Therapeutics reported a net margin of -2,865.76% for the quarter ended Jun 2026. These financial ratios cover 46 quarters of results from Dec 2014 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Dec2014 | Jun2015 | Sep2015 | Dec2015 | Mar2016 | Jun2016 | Sep2016 | Dec2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||||||||||||||||||||||||||||||||||||||
| EBT Margin | 53.86% | -688.06% | -3,769.52% | -5,298.60% | -1,741.26% | -225.33% | -13,694.25% | 38.00% | -13,552.90% | 27.76% | -6,227.64% | -4,322.37% | -5,749.16% | -2,865.76% | ||||||||||||||||||||||||||||||||
| EBIT Margin | 53.98% | -684.56% | -3,734.16% | -5,207.65% | -1,716.23% | -177.54% | -13,518.77% | 39.16% | -14,382.58% | 29.32% | -6,403.70% | -4,423.97% | -5,839.94% | -2,890.35% | ||||||||||||||||||||||||||||||||
| EBITDA Margin | 53.98% | -684.56% | -3,734.16% | -5,207.65% | -1,716.23% | -177.54% | -13,518.77% | 39.16% | -14,382.58% | 29.32% | -6,403.70% | -4,423.97% | -5,839.94% | -2,890.35% | ||||||||||||||||||||||||||||||||
| Operating Margin | 53.98% | -684.56% | -3,734.16% | -5,207.65% | -1,716.23% | -177.54% | -13,518.77% | 39.16% | -14,382.58% | 29.32% | -6,403.70% | -4,423.97% | -5,839.94% | -2,890.35% | ||||||||||||||||||||||||||||||||
| Net Margin | 53.86% | -688.06% | -3,769.52% | -5,298.60% | -1,741.26% | -225.33% | -13,694.25% | 36.81% | -15,759.03% | 32.93% | -6,227.64% | -4,322.37% | -5,749.16% | -2,865.76% | ||||||||||||||||||||||||||||||||
| FCF Margin | 97.57% | -740.08% | -4,648.02% | -4,281.25% | -1,766.23% | -5,779.79% | -15,450.57% | 51.20% | -19,694.19% | 38.31% | 626.21% | -3,365.07% | -4,569.83% | -3,042.66% | ||||||||||||||||||||||||||||||||
| Efficiency | ||||||||||||||||||||||||||||||||||||||||||||||
| Inventory AverageInventory Avg. | 11.93M | 24.09M | 35.81M | 47.48M | ||||||||||||||||||||||||||||||||||||||||||
| Assets AverageAssets Avg. | 332.97M | 375.58M | 337.37M | 296.54M | 292.53M | 330.33M | 309.49M | 338.29M | 387.04M | 363.15M | 349.93M | 331.50M | 250.24M | 159.28M | 152.00M | 153.99M | 143.64M | 140.83M | 127.91M | 109.60M | ||||||||||||||||||||||||||
| Invested CapitalInvested Cap. | 201.20M | 156.15M | 131.39M | 73.69M | 118.44M | 61.83M | 3.36M | 123.36M | 86.01M | 56.69M | 42.27M | 15.42M | 23.92M | 13.78M | ||||||||||||||||||||||||||||||||
| Asset Utilization RatioAsset Util. | 0.47 | 0.39 | 0.42 | 0.46 | 0.05 | 0.02 | 0.02 | 0.39 | 0.33 | 0.00 | 0.00 | -0.38 | -0.50 | 0.00 | 0.01 | 0.01 | 0.02 | |||||||||||||||||||||||||||||
| Leverage & Solvency | ||||||||||||||||||||||||||||||||||||||||||||||
| Interest Coverage RatioInterest Cover | 91.94 | -66.98 | -61.13 | -42.19 | -34.23 | -0.92 | -36.23 | 15.54 | -55.72 | |||||||||||||||||||||||||||||||||||||
| Debt Ratio | 0.06 | 0.07 | 0.16 | 0.19 | 0.16 | 0.15 | 0.19 | 0.25 | 0.28 | 0.28 | 0.30 | 0.32 | ||||||||||||||||||||||||||||||||||
| Times Interest Earned | 91.94 | -66.98 | -61.13 | -42.19 | -34.23 | -0.92 | -36.23 | 15.54 | -55.72 | |||||||||||||||||||||||||||||||||||||
| Valuation | ||||||||||||||||||||||||||||||||||||||||||||||
| Price to EarningsP/E | 9.37 | -15.41 | -11.67 | -4.91 | -13.32 | -319.18 | -10.04 | 13.17 | -6.27 | -4.55 | -2.88 | -3.34 | 1.45 | -5.06 | -4.59 | -4.00 | -7.71 | -7.51 | -4.13 | -3.68 | ||||||||||||||||||||||||||
| Price to SalesP/S | 5.04 | 106.00 | 439.74 | 260.37 | 231.92 | 719.23 | 0.00M | 4.85 | 987.55 | -1.50 | 480.43 | 324.66 | 237.66 | 105.35 | ||||||||||||||||||||||||||||||||
| Price to BookP/B | 3.64 | 5.82 | 8.11 | 13.73 | 11.82 | 65.03 | -14.99 | 27.12 | -20.24 | -4.21 | -1.96 | -1.26 | 6.73 | 10.43 | 2.42 | 2.95 | 3.86 | 3.22 | 3.21 | 2.25 | ||||||||||||||||||||||||||
| Enterprise Value | 166.12M | 474.73M | 313.73M | 51.85M | 538.11M | 519.90M | 611.24M | 383.78M | 136.23M | 61.09M | 6.03M | 38.55M | 94.19M | 112.98M | 63.40M | 51.88M | 120.99M | 96.43M | 55.25M | 61.95M | ||||||||||||||||||||||||||
| EV to EBIT | 2.43 | -9.60 | -5.63 | -0.82 | -9.10 | -300.35 | -8.66 | 7.75 | -3.06 | -1.65 | -0.18 | -1.34 | -3.23 | -3.92 | -2.33 | -2.09 | -5.38 | -4.98 | -2.64 | -2.91 | ||||||||||||||||||||||||||
| EV to EBITDA | 2.43 | -9.60 | -5.63 | -0.82 | -9.10 | -300.35 | -8.66 | 7.75 | -3.06 | -1.65 | -0.18 | -1.34 | -3.23 | -3.92 | -2.33 | -2.09 | -5.38 | -4.98 | -2.64 | -2.91 | ||||||||||||||||||||||||||
| Market Capitalization | 639.22M | 765.44M | 656.54M | 316.61M | 798.72M | 701.24M | 717.78M | 613.30M | 306.14M | 189.06M | 117.22M | 109.78M | 161.01M | 143.77M | 122.25M | 97.26M | 168.63M | 142.20M | 85.08M | 77.54M | ||||||||||||||||||||||||||
| Price to FCFP/FCF | 5.17 | -14.32 | -9.46 | -6.08 | -13.13 | -12.44 | -8.90 | 9.47 | -5.01 | -3.91 | -3.32 | -2.75 | -4.63 | -3.69 | 4.55 | -7.23 | 76.72 | -9.65 | -5.20 | -3.46 | ||||||||||||||||||||||||||
| EV to FCF | 1.34 | -8.88 | -4.52 | -1.00 | -8.85 | -9.23 | -7.58 | 5.93 | -2.23 | -1.26 | -0.17 | -0.97 | -2.71 | -2.90 | 2.36 | -3.86 | 55.05 | -6.54 | -3.38 | -2.77 | ||||||||||||||||||||||||||
| EV to CFO | 1.30 | -9.15 | -4.72 | -1.04 | -9.03 | -9.83 | -7.98 | 5.82 | -2.30 | -1.29 | -0.17 | -0.97 | -2.72 | -2.91 | 2.36 | -3.90 | 54.85 | -6.56 | -3.38 | -2.77 | ||||||||||||||||||||||||||
| Return Ratios | ||||||||||||||||||||||||||||||||||||||||||||||
| Return on Sales [ROS]ROS | 53.98% | -684.56% | -3,734.16% | -5,207.65% | -1,716.23% | -177.54% | -13,518.77% | 39.16% | -14,382.58% | 29.32% | -12,744.06% | 115.06% | 102.57% | -6,403.70% | -4,423.97% | -5,839.94% | -2,890.35% | |||||||||||||||||||||||||||||
| Return on Capital Employed [ROCE]ROCE | -13.83% | -21.99% | -33.30% | -48.24% | -108.02% | -73.52% | -79.26% | -31.45% | -21.88% | -38.81% | -26.46% | -64.92% | -69.85% | -102.76% | -94.56% | -89.49% | -85.33% | -77.34% | -80.73% | -93.82% | ||||||||||||||||||||||||||
| Return on Assets [ROA]ROA | -9.88% | -17.18% | -25.42% | -34.44% | -78.75% | -55.36% | -64.00% | -25.30% | -19.24% | -31.35% | -23.72% | -49.89% | -2.10% | 4.99% | 14.45% | 20.74% | -70.46% | -65.14% | -67.01% | -75.24% |